However, transcriptional silencing of EMP3 in neuroblastoma and glioma cell lines is associated with aberrant methylation at exon 1 of EMP3; hypermethylation level is associated with poor 2-year survival and neuroblastoma-caused mortality, indicating a tumor-suppressing function (37). This evidence concerns the gene EMP3 and central nervous system cancer.